Results 241 to 250 of about 393,410 (301)

Gut microbiota-derived metabolites in gastrointestinal cancer: immunomodulatory mechanisms via the tryptophan-AhR axis and translational perspectives. [PDF]

Front Immunol
Xing X, Ying H, Wang DX, Han S.
europepmc   +1 more source

The Cancer Cell Metabolic Reprogramming Remodels the Tumor Microenvironment: Molecular Mechanisms and Therapeutic Strategies

Advanced Science, EarlyView.
This review elucidates how cancer cell metabolic reprogramming—across glucose, lipid, amino acid, and nucleotide pathways—remodels the tumor microenvironment to suppress anti‐tumor immunity and promote immune escape. Targeting these metabolic axes offers promising strategies to overcome immunotherapy resistance and enhance cancer treatment.
Guoqing Xiang, Zhicheng Zhou, Xue Jiang, Zhenguang Du, Yangyang Zhan, Xinli Liu   +5 more
wiley   +1 more source

NLRP12 in cancer: a context-dependent regulator of tumor progression, immunity, and metabolism. [PDF]

Front Oncol
Cen Y, Li L, Ding X, Wang C, Qiu H.
europepmc   +1 more source

Bone marrow mesenchymal stem cells synergize with fusobacterium nucleatum to drive colorectal tumorigenesis via gut microbiome dysbiosis. [PDF]

Gut Pathog
Zhang K, Duan C, Chen J, He Q, Jin Y, Liu J, Lin R, Han C.   +7 more
europepmc   +1 more source

CYP8B1 suppressed by Ras/ERK leads to cholesterol accumulation and bile acids reduction and facilitates hepatic tumorigenesis. [PDF]

Cancer Metab
Li J, Li H, Dong L, Yao L, Dong X, Guo Y, Pu C, Wang A, Chen J.   +8 more
europepmc   +1 more source

Functional CRISPR Screens Define Genetic Drivers for Cancer Transformation and Progression from Non-Cancerous Cells. [PDF]

Int J Mol Sci
Ma S, Li Y, Fei T.
europepmc   +1 more source

<i>miR-218</i> Overexpression Suppresses Tumorigenesis of Papillary Thyroid Cancer via Inactivation of PTEN /PI3K/AKT Pathway by Targeting Runx2 [Retraction]. [PDF]

Onco Targets Ther
europepmc   +1 more source